Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has approved VOKANAMET® (a fixed-dose therapy combining canagliflozin and immediate release metformin hydrochloride in a single tablet) in the European Union, for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control.

26 Apr 2014

Professor wins 2014 Outstanding Scientific Achievement Award from American Diabetes Association

Dr. Joel Elmquist, Director of the Center for Hypothalamic Research at UT Southwestern Medical Center, has been awarded the American Diabetes Association's Outstanding Scientific Achievement Award, the organization's top honor for an early-career scientist.

26 Apr 2014

Studies reveal effect of almonds on diet quality, appetite, adiposity and cardiovascular disease risk factors

Six new almond-related research studies will be presented next week in San Diego at the American Society of Nutrition (ASN)'s Scientific Sessions and Annual Meeting, held in conjunction with Experimental Biology 2014 (EB).

26 Apr 2014

Concert Pharmaceuticals reports results from CTP-499 Phase 2 trial in patients with diabetic kidney disease

Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.

26 Apr 2014

FDA grants marketing approval to GlaxoSmithKline's diabetes drug based on Novozymes' Veltis technology

The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.

25 Apr 2014

New simple screening questionnaire designed to identify testosterone-deficient men

Men whose testosterone falls below normal levels are more likely to have erectile dysfunction and to be overweight and have heart disease and type 2 diabetes.

25 Apr 2014

Community-based structured weight loss program improves diabetes symptoms

Weight loss and control of blood sugar can reduce the risk of complications in patients with diabetes but this is difficult for many to achieve. A University of California, San Diego School of Medicine randomized controlled trial of obese adults with type 2 diabetes suggests that participants enrolled in a community-based structured weight loss program are able to shed more pounds, improve blood sugar control and reduce or eliminate insulin use and other medications compared to a control group.

25 Apr 2014

Increasing daily coffee consumption may lower type 2 diabetes risk

People who increased the amount of coffee they drank each day by more than one cup over a four-year period had a 11% lower risk for type 2 diabetes than those who made no changes to their coffee consumption, according to a new study led by Harvard School of Public Health (HSPH) researchers. In addition, the study found that those who decreased their coffee consumption by more than a cup per day increased their type 2 diabetes risk by 17%.

24 Apr 2014

New genetic evidence strengthens link between role of dietary fats with colon cancer progression

Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.

22 Apr 2014

New hypothesis about emergence of Parkinson's disease

The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells.

21 Apr 2014

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.

17 Apr 2014

EKF Diagnostics' new handheld Lactate Scout+ device ideal for checking sports medical health

Since Lactate Scout+ analyzer launch incorporating hematocrit compensation, EKF, is seeing an increasing interest from users in both sports and medical science.

From EKF Diagnostics 17 Apr 2014

Waist circumference, body mass index, and postmenopausal breast cancer incidence

A study of predominantly white women finds a larger waist circumference is associated with higher risk of postmenopausal breast cancer, but not beyond its contribution to BMI. The study, by American Cancer Society researchers, fails to confirm previous findings that body shape itself is an independent risk factor for breast cancer. The current study appears in the April 2014 issue of Cancer Causes, and Control.

16 Apr 2014

FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

16 Apr 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.

15 Apr 2014

Psychological support for diabetes patients: an interview with Katharine Barnard, University of Southampton

It’s been over a decade since the first Diabetes Attitudes Wishes and Needs (DAWN) study showed that psychosocial aspects of diabetes pose specific challenges and barriers to optimal glycaemic control for people living with diabetes.

15 Apr 2014

Researchers reveal why Peel has one of highest rates of diabetes in Ontario

According to researchers at St. Michael's Hospital, there are two significant reasons why Peel has one of the highest rates of diabetes in Ontario: neighbourhood design that discourages walking and a population with many residents whose ethnic backgrounds predispose them to diabetes.

11 Apr 2014

New edition of RADAR includes review of glycopyrronium for COPD treatment

NPS MedicineWise has published a new edition of RADAR, including a review of glycopyrronium (Seebri Breezhaler), a new medicine for the treatment of chronic obstructive pulmonary disease (COPD).

10 Apr 2014

IRB Barcelona scientists develop new drug target to prevent muscle deterioration in certain diseases

In the study published today in the Journal of Clinical Investigation (JCI), one of the journals with highest impact in experimental medicine, the researchers associate the activity of the DOR protein with muscle atrophy and point to DOR as a plausible target against which to develop a drug to prevent muscle deterioration in certain diseases.

10 Apr 2014

Researcher analyses effect of chromium supplementation on blood sugar

Approximately 26 percent of the U.S. population has impaired fasting glucose, which is a predisposition for developing type 2 diabetes, and chromium supplementation has been suggested as a method that may help control and prevent the disease.

10 Apr 2014

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

Professor wins 2014 Outstanding Scientific Achievement Award from American Diabetes Association

Studies reveal effect of almonds on diet quality, appetite, adiposity and cardiovascular disease risk factors

Concert Pharmaceuticals reports results from CTP-499 Phase 2 trial in patients with diabetic kidney disease

FDA grants marketing approval to GlaxoSmithKline's diabetes drug based on Novozymes' Veltis technology

New simple screening questionnaire designed to identify testosterone-deficient men

Community-based structured weight loss program improves diabetes symptoms

Increasing daily coffee consumption may lower type 2 diabetes risk

New genetic evidence strengthens link between role of dietary fats with colon cancer progression

New hypothesis about emergence of Parkinson's disease

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

EKF Diagnostics' new handheld Lactate Scout+ device ideal for checking sports medical health

Waist circumference, body mass index, and postmenopausal breast cancer incidence

FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Psychological support for diabetes patients: an interview with Katharine Barnard, University of Southampton

Researchers reveal why Peel has one of highest rates of diabetes in Ontario

New edition of RADAR includes review of glycopyrronium for COPD treatment

IRB Barcelona scientists develop new drug target to prevent muscle deterioration in certain diseases

Researcher analyses effect of chromium supplementation on blood sugar

Forensics and toxicology - Industry Focus eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Forensics and toxicology - Industry Focus eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in